Mitochondria‐targeted atovaquone promotes anti‐lung cancer immunity by reshaping tumor microenvironment and enhancing energy metabolism of anti‐tumor immune cells is a research paper published in Cancer Communications (2023). On theSindex it has a DataRank of 0. It has been cited 17 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01CA223804
National Institutes of Health
Grant: R01CA232433
National Institutes of Health
Grant: R01CA205633
National Institutes of Health
Grant: R01CA280746
National Institutes of Health
Grant: 1R01CA232433-01A1
Chemoprevention of lung cancer by targeting lonidamine to mitochondria
European Commission
Grant: 223804
India-Europe Cooperation to promote IPv6 adoption
National Institutes of Health
Grant: 5R01CA280746-02
Targeting phenethyl isothiocyanate to mitochondria in lung carcinogenesis
National Institutes of Health
Grant: 5R01CA223804-03
Chemoimmunoprevention of EGFR-Driven Non-Small Cell Lung Cancer
National Institutes of Health
Grant: 5R01CA205633-02
Inhibition of Oral Tumorigenesis by Antitumor B
FWCI
1.55
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals